In the present study we further investigate whether monocyte expression of STAT3 in the tumor microenvironment could promote tumor growth and whether the STAT3 inhibitor, NSC 74859, can prevent diethylinitrosamine (DEN)-induced HCC by suppressing STAT3 activation and its associated inflammation. The gene discussed is STAT3; the disease is neoplasm.